drugset / Trial / NCT00550849
Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
RandomizedSingle-groupTriple-blindTreatment
Summary
This study assesses the safety and tolerability of RTA 402 in patients with liver disease.
Timeline
- Start
- 2007-04-30
- Primary completion
- 2007-11-30
- Completion
- 2007-11-30
Outcome
Outcome not reported
Stopped (Enrollment): “Enrollment discontinued after second cohort completed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bardoxolone methyl | Small molecule | 5 mg | Oral |
| Subject | Bardoxolone methyl | Small molecule | 25 mg | Oral |
| Subject | Bardoxolone methyl | Small molecule | 50 mg | Oral |